Patents by Inventor Zhengyi FANG

Zhengyi FANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240169961
    Abstract: Provided are a method and apparatus for determining an audio, an electronic device, and a storage medium. The method includes: a chord corresponding to an input audio is determined in response to receiving the input audio; at least one to-be-selected arrangement style is determined according to the chord and/or a melody attribute of the input audio; at least one to-be-selected arrangement template associated with a target arrangement style is displayed based on a trigger operation to the at least one to-be-selected arrangement style; and a target audio is played based on a trigger operation to the at least one to-be-selected arrangement template.
    Type: Application
    Filed: August 11, 2023
    Publication date: May 23, 2024
    Inventors: Shuai YUAN, Bochen LI, Qiuhong XU, Na ZHAO, Zhengyi FANG, Peidao LI, Shengli WANG
  • Publication number: 20240142634
    Abstract: The present application provides a trusted space positioning calibration service system and an operation method thereof. The system includes: a differential benchmark data service module, a positioning data digital calibration server and a trusted space positioning calibration apparatus.
    Type: Application
    Filed: January 9, 2024
    Publication date: May 2, 2024
    Applicant: National Institute of Metrology, China
    Inventors: Xingchuang XIONG, Xiang FANG, Yanlin LIANG, Zhengyi ZHAO, Zhen LIU, Wenkui HE
  • Patent number: 11926662
    Abstract: Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: March 12, 2024
    Assignee: I-Mab Biopharma (Hangzhou) Co., Ltd.
    Inventors: Zhengyi Wang, Lei Fang, Bingshi Guo, Jingwu Zang